文献速递腹部US

使用全氟丁烷的超声造影:拟议的改良LI-RADS标准对肝细胞癌检出率的影响

Contrast-Enhanced Ultrasound Using Perfluorobutane: Impact of Proposed Modified LI-RADS Criteria on Hepatocellular Carcinoma Detection.
PubMed 文献 · AJR Am J Roentgenol · 2022-04-20

回顾性分析293例肝细胞癌高危患者共304个观察灶,比较超声造影LI-RADS v2017与针对全氟丁烷的改良标准中LR-5类别的诊断效能;改良标准纳入Kupffer期缺损,使敏感度从69%升至89%(p<.001),特异度从87%降至83%(无显著差异,p>.99),准确率从71%升至89%(p<.001)。

要点

  • 改良标准将10 mm及以上、非环状动脉期高增强、无廓清、伴Kupffer期缺损的病灶从LR-4升级为LR-5。
  • 改良标准将10 mm及以上、非环状动脉期高增强、早期廓清、伴轻度Kupffer期缺损的病灶从LR-M重分类为LR-5。
  • 改良标准较v2017显著提高HCC检出敏感度(89% vs 69%)和准确率(89% vs 71%),特异度降低无统计学意义(83% vs 87%)。

核心结论

  • 在高危患者中使用全氟丁烷行超声造影时,纳入Kupffer期缺损的改良标准可显著提高HCC检出敏感度,且特异度无显著下降。

研究设计与样本

  • 回顾性研究纳入293例HCC高危患者(259男、34女,平均年龄55±12岁),2020年3月1日至2020年10月30日行全氟丁烷超声造影,共304个观察灶(274个HCC、14个非HCC恶性肿瘤、16个良性病灶);两名阅片者独立评估并按CEUS LI-RADS v2017及拟议改良标准分类,评估阅片者间一致性并达成共识。

诊断标准与关键数值

  • 改良标准:10 mm及以上、非环状动脉期高增强、无廓清且伴Kupffer期缺损的观察灶从LR-4升级为LR-5;10 mm及以上、非环状动脉期高增强、早期廓清且伴轻度Kupffer期缺损的观察灶从LR-M重分类为LR-5。

临床应用与阅片要点

  • 采用全氟丁烷超声造影时,对10 mm及以上、非环状动脉期高增强且无廓清的病灶,应注意Kupffer期(注射后≥10分钟)是否出现缺损,以满足改良LR-5标准;对伴早期廓清和轻度Kupffer期缺损的病灶按改良标准归为LR-5;原文作者认为未来CEUS LI-RADS更新应考虑采纳所探索的标准。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Contrast-enhanced ultrasound (CEUS) LI-RADS version 2017 (v2017) applies only to CEUS examinations performed using pure blood pool agents, noting that future versions will address combined blood pool and Kupffer cell agents such as perfluorobutane. Such agents may improve hepatocellular carcinoma (HCC) detection by visualization of a defect in the Kupffer phase (obtained ≥ 10 minutes after injection). OBJECTIVE. The purpose of our study was to compare the diagnostic performance of the LR-5 category for HCC detection in at-risk patients between CEUS LI-RADS v2017 and proposed modified criteria for CEUS examinations performed using perfluorobutane. METHODS. This retrospective study included 293 patients at risk for HCC (259 men, 34 women; mean age, 55 ± 12 [SD] years) who underwent CEUS using perfluorobutane from March 1, 2020, to October 30, 2020, showing a total of 304 observations (274 HCC, 14 non-HCC malignancy, and 16 benign lesions). Two readers independently assessed examinations and assigned categories using both CEUS LI-RADS v2017 and the proposed modified criteria. In the modified criteria, observations 10 mm or greater with not rim arterial phase hyperenhancement (APHE), no washout, and a Kupffer defect were upgraded from LR-4 to LR-5, and observations 10 mm or greater with not rim APHE, early washout, and a mild Kupffer defect were reassigned from LR-M to LR-5. Interreader agreement was assessed, and consensus interpretations were reached. Diagnostic performance was evaluated. RESULTS. Interreader agreement for LI-RADS category assignments, expressed using kappa coefficients, was 0.839 for CEUS LI-RADS v2017 and 0.854 for the modified criteria. Modified criteria upgraded 35 observations from LR-4 to LR-5 on the basis of a Kupffer defect, of which 34 were HCC and one was benign. Modified criteria reassigned 22 observations from LR-M to LR-5 on the basis of a mild Kupffer defect, of which all were HCC. LR-5 using modified criteria, compared with CEUS LI-RADS v2017, had significantly increased sensitivity (89% vs 69%, p < .001), a nonsignificant decrease in specificity (83% vs 87%, p > .99), and significantly increased accuracy (89% vs 71%, p < .001) for HCC. CONCLUSION. When using perfluorobutane for CEUS in at-risk patients, modified criteria incorporating Kupffer defects significantly improve sensitivity without significant loss of specificity in HCC detection. CLINICAL IMPACT. Future CEUS LI-RADS updates seeking to address the use of combined blood pool and Kupffer cell agents should consider adoption of the explored criteria.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Li, Zheng, Wang, et al. Contrast-Enhanced Ultrasound Using Perfluorobutane: Impact of Proposed Modified LI-RADS Criteria on Hepatocellular Carcinoma Detection. AJR Am J Roentgenol. 2022. PMID: 35441534. doi:10.2214/AJR.22.27521

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。